GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kane Biotech Inc (TSXV:KNE) » Definitions » 12-1 Month Momentum %

Kane Biotech (TSXV:KNE) 12-1 Month Momentum % : 36.84% (As of Jun. 05, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Kane Biotech 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-05), Kane Biotech's 12-1 Month Momentum % is 36.84%.

The industry rank for Kane Biotech's 12-1 Month Momentum % or its related term are showing as below:

TSXV:KNE's 12-1 Month Momentum % is ranked better than
82.77% of 1480 companies
in the Biotechnology industry
Industry Median: -24.245 vs TSXV:KNE: 36.84

Competitive Comparison of Kane Biotech's 12-1 Month Momentum %

For the Biotechnology subindustry, Kane Biotech's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kane Biotech's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kane Biotech's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Kane Biotech's 12-1 Month Momentum % falls into.



Kane Biotech  (TSXV:KNE) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kane Biotech  (TSXV:KNE) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Kane Biotech 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Kane Biotech's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kane Biotech (TSXV:KNE) Business Description

Traded in Other Exchanges
Address
290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The Company has a separate operating segment for its Stem Animal Health subsidiary, which operates the animal health business. StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, DermaKB and DermaKB Biofilm are trademarks of the company. The firm is also engaged in the animal health business through its Stem Animal Health subsidiary.
Executives
Philip Renaud Director

Kane Biotech (TSXV:KNE) Headlines

No Headlines